Skip to main content
SpringerLink
Log in

Canagliflozin/metformin

Gastrointestinal side effects and euglycemic diabetic ketoacidosis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Breaux BM, et al. Euglycemic diabetic ketoacidosis-newer class of medication can lead to rare presentation of an old foe. Diabetes 67 (Suppl. 1): abstr. A604, Jul 2018. Available from: URL: https://doi.org/10.2337/db18-2314-PUB [abstract] - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Canagliflozin/metformin. Reactions Weekly 1718, 55 (2018). https://doi.org/10.1007/s40278-018-51399-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-51399-7

Search

Navigation